Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder

Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder

Plasma acylethanolamides (NAEs), including the endocannabinoid anandamide (AEA), have been proposed as circulating biomarkers of substance use disorders. However, the concentration of these lipid transmitters might be influenced by the use of drugs prescribed for either the treatment of addiction or...

Full description

Bibliographic Details
Main Authors: Jesús Herrera-Imbroda, María Flores-López, Nerea Requena-Ocaña, Pedro Araos, Jessica Ropero, Nuria García-Marchena, Antonio Bordallo, Juan Suarez, Francisco Javier Pavón-Morón, Antonia Serrano, Fermín Mayoral, Fernando Rodríguez de Fonseca
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
substance use disorders
biomarkers
endocannabinoids
acylethanolamides
neuroleptics
psychiatric co-morbidity
Online Access:https://www.mdpi.com/1422-0067/24/11/9371

Internet

https://www.mdpi.com/1422-0067/24/11/9371

Similar Items